Live feed08:00:00·6dPRReleasevia QuantisnowCalidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human StudyByQuantisnow·Wall Street's wire, on your screen.CLDI· Calidi Biotherapeutics Inc.Health Care
